Safety of mRNA vaccination for COVID-19 in children with polyethylene glycol (PEG)-asparaginase allergy

Pediatr Allergy Immunol. 2023 Mar;34(3):e13939. doi: 10.1111/pai.13939.

Authors

Rebecca Doyle^{1

2}, Mariana Melo¹, Cindy Teoh¹, Sophie Wen^{1

3}, Sophie Willcocks¹

Affiliations

¹ Children's Health Queensland Hospital and Health Service, South Brisbane, Australia.
² University of Queensland, School of Nursing, Midwifery and Social Work, St Lucia, Australia.
³ University of Queensland, Centre for Clinical Research, Herston, Australia.

PMID: 36974643
DOI: 10.1111/pai.13939

No abstract available

Keywords: COVID-19; PEG-asparaginase; hypersensitivity; vaccination.

Publication types

Letter

MeSH terms

Asparaginase / adverse effects
COVID-19* / prevention & control
Child
Drug Hypersensitivity*
Humans
Hypersensitivity*
Polyethylene Glycols / adverse effects

Substances

Asparaginase
Polyethylene Glycols